Last updated 2 months ago

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

426 patients around the world
Available in Spain, United States, Brazil
Cogent Biosciences, Inc.
2Research sites
426Patients around the world
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro de Estudos e Pesquisas de Hematologia e Oncologia - CEPHO
Recruiting
Av. Príncipe de Gales, 821 - Vila Principe de Gales, Santo André - SP, 09060-650
Hospital Universitario 12 de Octubre
Recruiting
Av. de Córdoba, s/n, 28041 Madrid
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy